178 related articles for article (PubMed ID: 12845514)
1. Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability.
Prentice HG
Support Care Cancer; 2003 Aug; 11(8):501-8. PubMed ID: 12845514
[TBL] [Abstract][Full Text] [Related]
2. Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
Kalaycio M; Mendez Z; Pohlman B; Overmoyer B; Boparai N; Jones E; Bolwell B
J Cancer Res Clin Oncol; 1998; 124(5):265-9. PubMed ID: 9645457
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
5. [Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
Yamasaki F; Watanabe Y; Nosaka R; Kenjo M; Nakamura K; Takayasu T; Saito T; Tominaga A; Sugiyama K; Kurisu K
No Shinkei Geka; 2014 Jan; 42(1):27-34. PubMed ID: 24388937
[TBL] [Abstract][Full Text] [Related]
6. Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. Italian Group for Antiemetic Research.
J Clin Oncol; 1995 Sep; 13(9):2417-26. PubMed ID: 7666102
[TBL] [Abstract][Full Text] [Related]
7. The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
Carmichael J; Harris AL
Cancer Chemother Pharmacol; 2004 Feb; 53(2):123-8. PubMed ID: 14634790
[TBL] [Abstract][Full Text] [Related]
8. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus injection].
Tsudo M; Moriguchi T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1747-53. PubMed ID: 9757201
[TBL] [Abstract][Full Text] [Related]
10. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.
Berrak SG; Ozdemir N; Bakirci N; Turkkan E; Canpolat C; Beker B; Yoruk A
Support Care Cancer; 2007 Oct; 15(10):1163-8. PubMed ID: 17372773
[TBL] [Abstract][Full Text] [Related]
12. The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
Climent MA; Palau J; Ruiz A; Soriano V; Aznar E; Olmos T; Guillem V
Support Care Cancer; 1998 May; 6(3):287-90. PubMed ID: 9629884
[TBL] [Abstract][Full Text] [Related]
13. Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.
Spartinou A; Nyktari V; Papaioannou A
Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1289-1297. PubMed ID: 29057666
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of granisetron for cancer patients undergoing platinum-based chemotherapy: comparison of 1 miligram versus 3 miligram doses in preventing nausea and vomiting.
Kurnianda J; Hisyam B; Wahyuningsih E; Hutajulu SH
Acta Med Indones; 2005; 37(4):210-3. PubMed ID: 16317218
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.
Orchard PJ; Rogosheske J; Burns L; Rydholm N; Larson H; DeFor TE; Ramsay NK; Weisdorf D
Biol Blood Marrow Transplant; 1999; 5(6):386-93. PubMed ID: 10595816
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of 1 mg/body and 3 mg/body of intravenous granisetron for the prevention of chemotherapy-induced nausea and vomiting and adverse events in hematological malignancy patients].
Motohashi S; Hori K; Ono T; Ohnishi K; Kawakami J
Yakugaku Zasshi; 2012; 132(5):675-81. PubMed ID: 22687700
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
18. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1095-101. PubMed ID: 9239162
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of oral granisetron hydrochloride for alleviation of delayed nausea and vomiting induced by CPT-11.
Ikeda M; Yasui M; Fukunaga H; Seshimo I; Takayama O; Ikenaga M; Yamamoto H; Ohue M; Sekimoto M; Monden M
Eur J Cancer Care (Engl); 2005 Dec; 14(5):435-9. PubMed ID: 16274464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
